Search results
Concord Biotech Limited is a R&D driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.
- About Us
Concord Biotech Limited is a R&D driven biopharma Company...
- R & D
R & D - Concord Biotech Limited
- Facilities
Facilities - Concord Biotech Limited
- Accreditation
Accreditation - Concord Biotech Limited
- About Us
Get all the information on Concord Biotech with historic price charts for NSE / BSE. Experts & Broker view also get the Concord Biotech Ltd. buy/sell tips detailed news, announcements,...
- 1,536.55
- 607.08
- 1,528.00
- 39,357
Concord Biotech IPO is a book built issue of Rs 1,551.00 crores, entirely an offer for sale of 2.09 crore shares. The issue was open for subscription from August 4 to August 8, 2023 and got listed on BSE, NSE on August 18, 2023.
- August 8, 2023
- 1482-86, Trasad Road Dholka, Gujarat
- August 4, 2023
Concord Biotech Limited (CBL) is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation -based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide.
Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has...
People also ask
Who is Concord Biotech?
What is Concord biotech IPO?
Who is Concord pharmaceuticals?
What are Concord products?
Incorporated in 1984, Concord Biotech Limited is an India-based R&D-driven biopharma company and manufacturer of fermentation-based APIs across immunosuppressants and oncology.